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We last reported our experience with simultaneous aor-
tic reconstruction and renal artery (RA) revascularization
for a series of 89 patients in 1987.1 At that time, we found
that both the operative mortality rate and the risk for post-
operative renal dysfunction were approximately twice as
high (15% vs 7%) among patients who had severe bilateral
RA disease than in patients who had only unilateral RA
involvement. Because the importance of bilateral RA dis-
ease intuitively appeared to represent a proxy for an ele-
vated serum creatinine level (SCr), with this report we
attempt to correlate the SCr with the early results and the
late outcome for a subsequent series of combined aortic
replacement and RA procedures that we performed during
another study period, extending from 1989 through 1997.
PATIENTS AND METHODS
On the basis of data entered prospectively into our
departmental computer registry, we performed infrarenal
or juxtarenal aortic replacement in conjunction with some
form of simultaneous RA revascularization for 103
patients from 1989 through 1997. Seven of these patients
were excluded from this analysis because they had rup-
tured aortic aneurysms (n = 2), infected aortic grafts (n =
2), an RA aneurysm (n = 1), concurrent intestinal
ischemia (n = 1), or an unobtainable hospital chart (n = 1).
Another 23 patients who underwent simultaneous recon-
struction of main (n = 9) and/or accessory RAs (n = 19)
for anatomic reasons also were omitted from consideration
because these vessels merely arose from the segment of the
aorta that was to be replaced with a synthetic graft. The
remaining 73 patients, who represent our study group,
received simultaneous RA revascularization because of
uncontrolled hypertension, deteriorating renal function
that was associated with either severe (>70%) RA stenosis
or at least 50% stenosis of the RA supplying a solitary func-
tioning kidney, or both. The preoperative SCr was 2
mg/dL or lower in 45 of these 73 patients (group R1;
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Purpose: We documented the postoperative complication rate and the late results of simultaneous infrarenal aortic
replacement and renal artery (RA) revascularization at the Cleveland Clinic and correlated these findings with the pre-
operative serum creatinine level (SCr) and other baseline risk factors.
Methods: A retrospective review of hospital charts and outpatient records was supplemented with a telephone canvass
and the invitation to return for a complimentary RA duplex scan, when a scan had not been done within the previous
year. Data were collected for 73 consecutive patients (mean age, 69 years) who underwent aortic procedures that were
combined with the repair of RA stenosis from 1989 to 1997 (mean follow-up, 44 months). The preoperative SCr was
2 mg/dL or lower in 45 patients (group R1; median, 1.5 mg/dL) and was higher than 2 mg/dL in the remaining 28
patients (group R2; median, 2.6 mg/dL).
Results: Forty-seven of the patients in this series had aortic aneurysms, 15 patients had aortoiliac occlusive disease, and
11 patients had both types of lesions. Bilateral RA revascularization was necessary for seven patients in group R1 (15%)
and for eight patients in group R2 (29%). Group R2 contained more patients with medically resistant hypertension
(57%) than group R1 (29%, P = .019). Although there was no statistically significant difference between the 30-day
mortality rates (group R1, 2.2%; group R2, 11%), the related in-hospital mortality rate for 15 bilateral RA revascular-
izations (13%) was nearly twice that of 58 unilateral revascularizations (6.9%). Patients in group R2 were at a higher
risk for postoperative dialysis than those in group R1 (36% vs 6.7%, P = .008), and patients in group R2 had longer
lengths of stay in the hospital (median, 14 days vs 9 days; P = .004). By means of Kaplan-Meier analysis, the 5-year
survival rate was lower for patients in group R2 (53%; 95% CI, 33%-73%) than for patients in group R1 (85%; 95% CI,
74%-96%; log rank P = .005). Despite all other liabilities in group R2 patients, however, their resistant hypertension
was cured or improved in 88% of cases and their SCr appeared to decline with time.
Conclusion: The early postoperative risk of simultaneous aortic/RA procedures appears to be highest in patients who
have an elevated SCr, bilateral RA stenosis or occlusion, and a comparatively low long-term survival rate. In this par-
ticular group, the adjunctive use of endovascular techniques might conceivably reduce the magnitude of the planned
surgical procedure and thus enhance the overall outcome. (J Vasc Surg 2001;34:1041-9.)
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Table I. Patient characteristics
Group R1 Group R2
Number % Number %
Patients 45 100 28 100
Mean age (years) 70 ± 8 68 ± 8
Men 31 69 14 50
Women 14 31 14 50
Aortic pathology
Aneurysm 30 66 17 60
Occlusive disease 7 16 8 29
Both 8 18 3 11
Main renal artery stenosis: ipsilateral to revascularization n = 52 n = 36
<50% 0 – 0 –
50%-70% 1 2 3 8
>70% 49 94 28 78
Occluded 0 – 4 11
Not visualized 1 2 1 3
Angiogram unavailable 1 2 0 –
Main renal artery stenosis: contralateral to revascularization n = 38 n = 20
<50% 13 34 4 20
50%-70% 9 24 3 15
>70% 6 16 4 20
Occluded 9 24 8 40
Not visualized 1 2 1 5
Angiogram unavailable 0 – 0 –
Antihypertensive medications
None 5 11 0 –
1-2 21 47 10 36
3 or more 19 42 18 64
Resistant hypertension 13 29 16 57
Serum creatinine level
<1.5 mg/dL 25 56 0 –
1.5-2.0 mg/dL 20 44 0 –
>2.0 mg/dL 0 – 28 100
Cardiac history
Myocardial infarction 17 38 14 50
Congestive heart failure 1 2 6 21
Coronary bypass surgery 19 42 15 54
Miscellaneous
Diabetes mellitus 1 2 6 221
Earlier stroke 2 4 5 18
Leg claudication/ischemia 25 55 10 36
Table II. Surgical reconstruction
Group R1 (n = 45) Group R2 (n = 28)
Number % Number %
Dacron aortic graft
Straight 6 13 5 18
Aortobiiliac 29 65 14 50
Aortobifemoral 5 11 6 21
Aortoilio/femoral 5 11 0 –
Other 0 – 3 11
Main renal artery revascularization 52 100 36 100
(7 bilateral) (8 bilateral)
Dacron graft 45 86 27 75
Vein graft 0 – 1 3
Endarterectomy 7 14 8 22
Accessory renal artery reimplantation 2 4 4 14
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median SCr, 1.5 mg/dL) and was higher than 2 mg/dL in
28 patients (group R2; median SCr, 2.6 mg/dL).
Perioperative data were collected by means of a review
of every hospital chart, and late postoperative information
(range, 0-113 months; mean, 44 months) was obtained
from outpatient records or by means of telephone contact
with patients, their families, or their referring physicians.
Three patients from group R1 were lost to follow-up.
Each patient who survived and had not been reevaluated
at our center within the preceding year was offered a com-
plimentary RA duplex scan to encourage compliance with
our customary annual surveillance protocol. The severity
of hypertension was classified according to guidelines
established by the National High Blood Pressure
Education Program (NHBPEP) and was defined as resis-
tant when the preoperative blood pressure could not be
reduced to less than 140/90 mm Hg despite the use of
three antihypertensive medications at near-maximal
dosages.2 Hypertension was considered to be improved
with surgical treatment when the postoperative blood
pressure could be reclassified to a more favorable category
or could be controlled with fewer medications under the
NHBPEP criteria.
Statistical analysis. Groups R1 and R2 were com-
pared for baseline demographics and risk factors by using
chi-square tests for categorical variables and either analysis
of variance or the non-parametric Kruskal-Wallis test for
continuous variables. We assessed whether 30-day mortal-
ity rates, dialysis rates, and other early outcomes were
influenced by the SCr classification of our study groups or
by other baseline factors with logistic regression analysis.
Kaplan-Meier survival analysis and Cox proportional haz-
ards regression were used as a means of comparing the
long-term survival rates in the study groups and adjusting
for potential confounding baseline risk factors. Changes in
the SCr and the blood pressure with time and the number
of antihypertensive medications that were necessary were
investigated by using random coefficient analysis of vari-
ance, allowing a unique slope and intercept for each sub-
ject. Pairwise comparisons among the groups were made
as appropriate, and a Bonferroni correction was applied to
the significance criterion. The significance level for each
hypothesis was .05. SAS statistical software (Cary, NC)
was used for all analyses.
Patient characteristics. Table I contains a summary
of selected clinical features for our study population. The
series included 45 men and 28 women (mean age, 69
years). Forty-seven patients had abdominal aortic
aneurysms (AAAs), whereas 15 patients had atheroscle-
rotic aortoiliac occlusive disease (ASO), and 11 patients
had both AAAs and ASO. Over 70% stenosis (n = 77) or
occlusion (n = 4) was documented by means of preopera-
Table III. Early complications
Group R1 (n = 45) Group R2 (n = 28)
Number % Number %
Related postoperative death 2 4.4 4 14
≤30 days 1 2.2 3 11
>30 days (still hospitalized) 1 2.2 1 3.6
Serum creatinine level
Preoperative mean 1.5 ± 0.3 mg/dL 3.2 ± 1.3 mg/dL
Preoperative median 1.5 mg/dL 2.6 mg/dL
Peak postoperative mean 1.8 ± 1.2 mg/dL 4.5 ± 2.2 mg/dL
Peak postoperative median 1.6 mg/dL 4.6 mg/dL
Hospital discharge mean 1.5 ± 1.0 mg/dL 3.1 ± 1.6 mg/dL
Hospital discharge median 1.3 mg/dL 2.6 mg/dL
Dialysis requirement
Preoperative 0 – 2 7.1
Postoperative 3 6.7 10 36
Hospital discharge 3 6.7 9 32
Cardiopulmonary events
Congestive heart failure 4 8.9 8 29
Myocardial infarction 2 4.4 2 7.1
Pneumonia 4 8.9 2 7.1
ARDS 3 6.7 3 11
Miscellaneous
Endotracheal intubation mean 2.0 ± 5.2 days 7.8 ± 2.5 days
Endotracheal intubation median 1 day 1 day
ICU stay mean 4.2 ± 6.3 days 14 ± 32 days
ICU stay median 2 days 3 days
LOS mean 11 ± 6.0 days 25 ± 30 days
LOS median 9 days 14 days
ARDS, Adult respiratory distress syndrome; ICU, intensive care unit; LOS, length of stay.
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tive angiography in 81 of the 88 (92%) RAs that under-
went surgery. Either a >70% stenosis (n = 10) or an occlu-
sion (n = 17) also was present in 27 (47%) of the
contralateral RAs for which simultaneous revascularization
was not performed. The decision not to attempt bilateral
RA procedures in the 10 patients who had a >70% steno-
sis of a patent contralateral RA was influenced primarily by
the presence of an atrophic kidney measuring less than 8
cm in polar length on that side. Split renal function tests
were not obtained during the period of this study.
Sixty-eight of the 73 patients (93%) had hypertension,
including 37 patients (51%) who required three or more
antihypertensive medications and 29 patients (40%) who
were resistant to medical treatment. The number of anti-
hypertensive medications (P = .037) and the incidence of
resistant hypertension (P = .017) were higher in group R2
than in group R1. The SCr was higher by definition in
group R2 (median, 2.6 mg/dL) than in group R1
(median, 1.5 mg/dL), but more patients in group R2 also
had a history of congestive heart failure (CHF; P = .01),
coronary artery bypass surgery (CAB; P = .044), or dia-
betes mellitus (P = .01).
The earlier cardiac history was positive for myocardial
infarction (MI) in 31 patients, for CHF in seven patients,
and for CAB in 34 patients. Preoperative echocardiogra-
phy was obtained in 42 patients, stress electrocardiography
or non-exertional myocardial imaging was obtained in 40
patients, and cardiac catheterization was obtained in 40
patients. As a consequence of these studies, 11 patients
underwent percutaneous transluminal coronary angio-
plasty (n = 3) or preliminary CAB (n = 8) before their aor-
tic replacement and simultaneous RA procedures. No
significant differences could be identified between the two
cohorts in this series for the prevalence of coronary artery
disease (Table I).
Surgical reconstruction. The surgical procedures
that were performed in this series of patients are summa-
rized in Table II. A total of 59 Dacron aortic bifurcation
grafts were constructed to the common iliac arteries in 43
patients, to the common femoral arteries in 11 patients,
Fig 1. Kaplan-Meier survival estimates for all 73 patients in this
series.
Fig 2. Long-term slope and intercept for diastolic blood pressure
(BP) in 63 patients for whom at least two late diastolic BP values
were available for analysis in a random coefficients model.
Table IV. Early blood pressure response in 67 patients who survived surgery
Cured Improved Unchanged Worse
Preoperative BP classification Number Number % Number % Number % Number %
Normal or non-resistant HTN 41 1 2 18 44 10 25 12 29
Group R1 30 1 3 13 44 7 23 9 30
Group R2 11 0 – 5 46 3 27 3 27
Resistant HTN 26 2 8 21 80 2 8 1 4
Group R1 12 1 8 10 84 1 8 0 –
Group R2 14 1 7 11 79 1 7 1 7
Total 67 3 5 39 58 12 18 13 19
Group R1 42 2 5 23 55 8 19 9 21
Group R2 25 1 4 16 64 4 16 4 16
BP, Blood pressure; HTN, hypertension.
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Fig 4. Long-term slope and intercept for 100/creatinine in a
total of 46 patients who did not undergo dialysis and for whom
at least two late serum creatinine values were available for analy-
sis in a random coefficients model.
and to one iliac artery and the contralateral femoral artery
in five patients. Straight aortic grafts were feasible in 11
patients, and three patients in group R2 underwent addi-
tional femorofemoral bypass grafting as a means of restor-
ing flow to one leg. Fifteen of the 73 patients (21%)
received bilateral RA revascularization. Of the 88 RAs that
underwent surgery, 72 (82%) were repaired by using ret-
rograde Dacron grafts, 15 (17%) by using endarterectomy,
and one with a saphenous vein graft. The median intraop-
erative RA clamp occlusion time was approximately 30
minutes, and a bolus (150 to 200 mL) of cold kidney per-
fusate was routinely infused into the RA soon after the
clamp had been applied. With the exception of occasional
interrogation with a sterile Doppler probe, we did not
routinely use intraoperative RA assessment in conjunction
with revascularization.
RESULTS
Operative mortality. There were six related postoper-
ative deaths (8.2%), four of which (5.5%) occurred within
30 days (Table III). The 30-day mortality rate was 11% in
group R2, but this was not significantly higher than the
Fig 3. Long-term slope and intercept for the number of antihy-
pertensive medications that were prescribed in 63 patients for
whom this information was available for analysis in a random
coefficients model.
Table V. Long-term survival
Group R1 (n = 45) Group R2 (n = 28)
Number % Number %
Follow-up intervals
Alive 36 80 13 46
Mean 51 mos 49 mos
Median 50 mos 45 mos
Dead 9 20 15 54
Mean 35 mos 26 mos
Median 31 mos 16 mos
Cumulative survival
Kaplan-Meier estimates (95% CI) (95% CI)
1 year 93% 78%
(85%, 100%) (63%, 94%)
3 years 85% 58%
(74%, 96%) (38%, 77%)
5 years 85% 53%
(74%, 96%) (33%, 73%)
Risk ratio 1.0 3.4
(1.5, 7.8)
P = .004
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rate in group R1 (2.2%, P = .13). The other two deaths
(2.1%) occurred at 35 days and at 107 days while each of
these patients was still in the hospital. Six patients died with
multiple system organ failure, including five patients who
required postoperative hemodialysis. The related mortality
rates were 6.9% (4/58) for unilateral RA revascularization
and 13% (2/15) for bilateral RA procedures (P = .24).
Postoperative complications. The absolute number
of several complications also appeared to be concentrated
in group R2 (Table III). The peak SCr (median, 4.6
mg/dL) and the SCr at the time of early death or discharge
from the hospital (median, 2.6 mg/dL) were significantly
higher in this cohort (P < .001). Thirteen patients
required postoperative dialysis, including three patients
(6.7%) in group R1 and 10 patients (36%) in group R2 (P
= .003). Renal artery revascularization was documented to
be patent in all 11 of these 13 patients for whom imaging
was performed. In group R2, the mean preoperative SCr
was 3.8 mg/dL (median, 3.5 mg/dL) in the 10 patients
who required postoperative dialysis, compared with 2.8
mg/dL (median, 2.5 mg/dL) in the 18 patients who did
not require postoperative dialysis (P = .11). Although no
significant differences in the incidence of cardiopulmonary
events could be identified, the observation that nearly 30%
of the patients in group R2 experienced postoperative
CHF may reflect the intolerance of these patients to even
marginal fluid overload. As a consequence of their com-
plications, patients in group R2 had longer periods of
endotracheal intubation (P = .02) and hospital length of
stay (P = .004).
Early blood pressure response. Forty-four of the 73
patients had either normal blood pressure (BP) preopera-
tively (n = 5) or hypertension that was adequately con-
trolled with medical management (n = 39), whereas 29
patients had resistant hypertension despite intensive drug
therapy. By using NHBPEP criteria,2 we summarize the
BP status of the 67 patients who survived surgery at the
time that they were discharged from the hospital in Table
IV. On the basis of these observations, we found that
hypertension appeared to be cured or improved in 63% of
patients, unchanged in 18% of patients, and worse in 19%
of patients. A favorable early response occurred in 23 of
the 26 patients (88%) who previously had resistant hyper-
tension, compared with 19 of the other 41 patients (46%,
P < .001).
Long-term survival. Given that three patients were
lost to follow-up soon after they were discharged from the
hospital, six early deaths and 18 documented late deaths
have occurred in this series. Kaplan-Meier estimates of
overall late survival were significantly worse for group R2
than for group R1 (P = .004; Table V; Fig 1). Five-year
survival rates were 53% (95% CI, 33%-73%) in group R2
and 85% (95% CI, 74%-96%) in group R1. Four of the 11
late deaths in group R2 were cardiac-related, compared
with one of the seven late deaths in group R1. A previous
history of CHF (P = .018), abnormal results on electro-
cardiogram (P = .037), abnormal results on non-exer-
tional myocardial imaging (P = .047), and an elevated
blood urea nitrogen level also were associated with signif-
icantly higher long-term mortality rates by means of uni-
variable analysis. However, only the stratification of
groups R1/R2 on the basis of the preoperative SCr had
statistical significance (P = .004) by means of multivariable
analysis.
Late blood pressure control. Sixty-three of the 67
patients who were discharged alive from the hospital have
had at least two subsequent BP measurements reported in
their Cleveland Clinic records, with a mean of 3.6 mea-
surements. These data were analyzed with random coeffi-
cient models in which every patient was accorded an
independent intercept and slope, giving greater statistical
weight to those patients for whom the most BP observa-
Table VI. Objective late patency
Group R1 (n = 43) Group R2 (n = 24)
Number % Number %
Late duplex scans or angiograms 22 51 9 38
Follow-up intervals for all studies
Mean 44 ± 30 mos 40 ± 29 mos
Median 47 mos 45 mos
Renal artery reconstruction
0%-59% stenosis 18 82 7 78
60%-99% stenosis 3 14 2 22
Occluded 1 4 0 –
Follow-up intervals >6 months only
Mean 51 ± 27 mos 45 ± 27 mos
Median 53 mos 48 mos
Renal artery reconstruction
0%-59% stenosis 15 79 6 75
60%-99% stenosis 3 16 2 25
Occluded 1 5 0 –
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tions were available. The baseline BP for this analysis was
the last recorded value before the patient was discharged
from the hospital. Although the absolute value for dias-
tolic BP appeared to decline during surveillance in group
R2 in comparison with group R1 (Fig 2), this finding was
not statistically significant and must be interpreted with
caution (a slope [SE] of –0.50 [± 0.82] mm Hg per year
in group R2 vs +0.11 [± 0.40] mm Hg per year in group
R1; P = .50). Any improvement in BP control also was
associated with a trend toward a higher number of antihy-
pertensive medications during the same follow-up interval
in both groups (a slope [SE] of +0.11 [± 0.03] medica-
tions per year in group R2, vs +0.10 [± 0.06] in group R1;
P = .87; Fig 3). However, the only significant finding in
this analysis was an increasing requirement for antihyper-
tensive medications in group R1 (P < .001).
Late renal function. Of the 67 patients who were
discharged from the hospital alive, the postoperative SCr
was improved by a factor of at least 20% in comparison
with the preoperative SCr in 16 patients (18%), remained
the same in 44 patients (50%), and became worse in 29
patients (32%). Five of the 13 patients (38%) who received
postoperative dialysis died in the hospital, and another
patient no longer needed dialysis at the time of discharge
from the hospital. Three of the remaining seven patients
later were successfully withdrawn from dialysis. Long-term
dialysis continued to be necessary for one of the 44 (2.3%)
patients who survived surgery in group R1 and for three
of the 24 patients who survived surgery (12%) in group
R2. Three of these four patients died during the follow-up
period. Only one of the other 64 patients who survived
surgery (1.6%) eventually received dialysis.
Forty-six of the 63 patients who did not receive dialy-
sis and who were discharged alive from the hospital had at
least two subsequent SCr measurements reported in their
Cleveland Clinic records, with a mean of 3.1 measure-
ments. These data also were analyzed by means of a ran-
dom coefficients model, preferentially with the parameter
of 100/SCr because its discriminatory properties often are
more dependable than those for the absolute value for SCr.
The baseline SCr for this analysis was the last recorded
value before the patients were discharged from the hospi-
tal. The results of this analysis (Fig 4) suggest that there
may have been gradual improvement of the SCr in group
R2 (a slope [SE] of +2.5 [± 1.6] in 100/SCr per year, P =
.14) compared with slight worsening of the SCr in group
R1 (a slope [SE] of –2.4 [± 0.85] in 100/SCr per year, P
= .007). The SCr slopes were significantly different for
groups R1/R2 (P = .01), but this finding could conceiv-
ably be related to the statistical phenomenon of regression
to the mean, a potential bias that sometimes is unavoid-
able when the comparison groups are defined by means of
the same variable that is used to measure outcome.
Late patency. Some form of objective imaging has
been obtained for 31 of the 67 (46%) patients who sur-
vived surgery. The most recent results are presented in
Table VI. Twenty-seven of the 31 patients have been stud-
ied more than 6 months after surgery, revealing a less than
60% RA stenosis in 21 patients (77%), a 60% to 99% steno-
sis in five patients (19%), and a occlusion in one patient
(4%). One patient for whom RA endarterectomy originally
had been performed was discovered to have recurrent
stenosis 2 years later and underwent percutaneous translu-
minal angioplasty (PTA) with intraluminal stenting to
repair this lesion.
DISCUSSION
An SCr of 2 mg/dL or higher is associated with suffi-
cient impairment of renal function to produce a measur-
able reduction in the glomerular filtration rate.3
Information from several major centers suggests that
patients with this degree of renal impairment have a com-
paratively high incidence of postoperative complications,
dialysis dependency, and late death after RA revasculariza-
tion, irrespective of whether it is performed independently
or in conjunction with aortic procedures.4-6 A number of
factors probably influence the ultimate outcome in such
patients, including age, coexistent coronary artery disease,
and the irretrievable loss of functioning renal mass. In
addition, the surgical risk in these patients may also be
related to their relative intolerance to the intravascular and
extravascular fluid shifts that often accompany long, com-
plex operations. As a possible example, Hansen et al7
recently reported that all but one of the 17 early deaths in
a series of 232 patients who underwent RA revasculariza-
tion for ischemic nephropathy (SCr > 1.8 mg/dL)
occurred after either bilateral RA reconstruction or unilat-
eral RA reconstruction combined with aortic repair.
Earlier literature relating specifically to simultaneous
aortic replacement and RA revascularization is difficult to
collate because case mix, the preferred approach for RA
revascularization (endarterectomy or bypass grafting), and
the methods used to calculate late results often are incon-
sistent. Data from representative articles that have been
published since 1984 are presented in Table VII.
Collectively, these series include 710 patients (men, 61%)
with a mean age of 65 years and a median follow-up
period of 38 months for patients who survived surgery.
On the basis of available data, we found that approxi-
mately 55% of the patients (298/540) had AAAs and 45%
of the patients (242/540) had ASO as their indication for
aortic replacement. The indication for RA revasculariza-
tion was hypertension in 69% of the 710 patients and/or
preservation of renal function in 32%. Bilateral RA proce-
dures were performed in 226 patients (32%). Of the 940
RAs that underwent surgery, 584 (62%) were treated with
bypass grafting, 311 (33%) with endarterectomy, and the
remaining 45 (5%) with reimplantation. The overall oper-
ative mortality rate was 6%, and postoperative dialysis was
necessary in 5% of patients. According again to the avail-
able data, hypertension was improved in 61% of patients
(323/529), unchanged in 22% of patients (104/479),
and worse in 2% of patients (10/429). Dialysis eventually
became necessary in 5% of patients (21/412), and the
crude late mortality rate varied widely from 5% to nearly
40%. Although operative mortality was substantially
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higher for bilateral RA revascularization in some of the
cited reports,1,9 O’Mara et al10 were able to perform 32
bilateral procedures with only a single death (3%). Despite
a mean preoperative SCr of 3.1 mg/dL in their series,
Chaikof et al14 also had only one early death (2%).
Nevertheless, the cumulative 5-year mortality rate was
39% in that series, and 32% of the patients who had a pre-
operative SCr of 3 mg/dL or higher required chronic dial-
ysis within 3 years after their operations.
All 73 patients in our series had traditional indications
for RA intervention in addition to their infrarenal aortic
disease. With the exception that their preoperative hyper-
tension was more severe, patients with a baseline SCr of 2
mg/dL or higher (group R2) were comparable demo-
graphically to those with an SCr less than 2 mg/dL (group
R1). Nevertheless, the results of simultaneous operations
were much less favorable in group R2. These patients had
an operative mortality rate of 14% and were significantly
more likely to require postoperative dialysis, to have a long
hospital length of stay, and to die within the next 5 years.
(The operative mortality rate also was higher for bilateral
RA revascularization in both groups. Although this com-
parison was not statistically significant, the early mortality
rates for bilateral and unilateral RA procedures in this
study [15% vs 7%] are nearly identical to those that we
reported for our original series of combined RA/aortic
operations in 1987.1) Despite their surgical risk and their
relatively poor long-term survival, patients in group R2
had similar improvement in their hypertension as the
patients in group R1, and their SCr appeared to decline
with time. The important question, therefore, is how
these late benefits can be attained with a lower risk for
early complications.
In view of the impact that catheter-based intervention
already has begun to have on other aspects of traditional
vascular surgery, it now may be appropriate to consider
the use of endovascular techniques in the treatment of
patients with synchronous renovascular and infrarenal
aortic disease. Although our published experience with
staged PTA/stenting of RA stenosis before suprarenal
aortic replacement is anecdotal,19 we also have occasion-
ally used this approach either before or after graft replace-
ment of infrarenal AAAs to reduce the magnitude of
aortic procedures in selected patients. The risk of con-
ventional contrast agents in the presence of impaired
renal function can be reduced by the use of gadolinium or
CO2 imaging, and recent reports suggest that the results
of renal PTA in conjunction with intraluminal stenting
are at least comparable with those that previously have
been described for surgical revascularization.20-22 Wong
et al23 have warned that secondary operative repair for
recurrent RA stenosis was made more difficult by the fail-
ure of earlier PTAs in 32 of their 51 patients (63%), but
other authors have not found this to be the case in smaller
series.24,25 Although its role is still far from clear in this
particular setting, transfemoral stent grafting of infrarenal
AAAs may also find an application in some patients with
associated RA disease. Endovascular AAA repair often
requires a relatively large volume of contrast medium,
however. Accordingly, RA revascularization may need to
be done as a preliminary procedure in these circum-
stances, either by means of PTA/stenting or perhaps with
bypass grafts from the hepatic or splenic arteries on the
right or left side, respectively. Although the usefulness of
these potential options has yet to be demonstrated and
might not surpass that of a traditional surgical approach,
they are mentioned in the specific context of our results
in group R2 merely in an attempt to encourage future
innovation for a subset of patients who often have been
difficult to treat safely in the past.
We thank Becky Roberts for maintaining the com-
puter database for this study and Geoffrey S. Cox, FRACS,
(Melbourne, Australia) and Timothy M. Sullivan, MD,
Table VII. Data from selected series
Indication for
Mean age Mean follow-up renal repair*
Series Year Patients (years) (months) HT Scr
Dean8 1984 50 59 NA 49 7
Sterpetti9 1986 39 62 30 36 15
Cleveland Clinic1 1987 89 63 37 43 37
O’Mara10 1988 32 67 28 32 18
Piquet11 1988 43 61 38 29 12
Atnip12 1990 29 66 32 13 8
DeRose13 1991 21 67 39 21 11
Chaikof14 1994 50 66 49 48 50
McNeil15 1994 101 64 40 66 23
Cambria16 1995 170 68 100 71 20
Clair17 1995 43 68 23 38 28
Kulbaski18 1998 43 63 44 43 0
HT, Hypertension; Scr, serum creatinine level (renal function); NA, data not available.
*Excluding incidental asymptomatic renal artery stenosis.
†Variably calculated (entire series/patients who survived surgery).
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(Greenville, SC) for contributing to this series while they
were members of our department from 1990 to 1992 and
1994 to 1998, respectively.
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Bilateral renal Hypertension Mortality
reconstruction results† Dialysis rate
Number % Improved (%) Unchanged (%) Worse (%) Postoperative (%) Late (%) Postoperative (%) Late (%)
9 18 81 19 – 14 2 12 NA
14 36 75 19 6 3 8 10 NA
16 18 63 37 – 10 NA 10 23
32 100 91 6 3 3 3 3 16
3 7 65 27 8 2 2 7 14
8 28 64 36 – 3 12 10 12
7 33 100 – – 0 0 5 5
21 42 50 NA NA 0 18 2 39
36 36 74 23 3 5 6 1 20
28 16 68 NA NA 6 NA 6 21
32 74 83 17 – 5 0 5 13
20 47 50 50 – 0 0 5 20
